Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03674827
Title A Study To Evaluate Escalating Doses of A Vaccine-Based Immunotherapy Regimen For NSCLC and TNBC
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Pfizer
Indications

triple-receptor negative breast cancer

lung non-small cell carcinoma

Therapies

PF-06936308

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.